View Older Stories
-
Cardinal Health raises 2026 earnings forecast to at least $10
-
Cardinal Health (CAH) PT Raised to $222 at Mizuho
-
These are the best U.S. healthcare tech and distribution stocks to buy: Barclays
-
Cardinal Health (CAH) call put ratio 3.4 calls to 1 put as share price up 13.7%
-
Cardinal Health (CAH) Tops Q1 EPS by 36c, provides guidance
-
Cardinal Health plans new Indianapolis distribution center
-
Cardinal Health (CAH) PT Raised to $186 at Leerink Partners
-
Cardinal Health (CAH) Files Mixed Shelf
-
Cardinal Health (CAH) Tops Q4 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
-
Cardinal Health to acquire Solaris Health for $1.9 billion
-
Cardinal Health (CAH) PT Raised to $190 at Jefferies
-
UBS Reiterates Buy Rating on Cardinal Health (CAH)
-
Cardinal Health (CAH) PT raised to $180 at Evercore ISI following investor day
-
Cardinal Health (CAH) Details Momentum and Updated Long-Term Value Creation Plans
-
TD Cowen Expects Cardinal Health (CAH) to Raise its LT Pharma Profit Guide
-
Cardinal Health (CAH) PT Raised to $170 at BofA Securities
-
Citius Oncology (CTOR) stock soars on distribution deal
-
Citius (CTOR) enters distribution agreement with Cardinal Health (CAH)
-
Wells Fargo Upgrades Cardinal Health (CAH) to Overweight
-
Cardinal Health (CAH) PT Raised to $177 at Leerink Partners
-
Cardinal Health (CAH) PT Raised to $175 at Evercore ISI
-
Charles River to initiate a review amid Elliott stake - Is a sale next?
-
Cardinal Health (CAH) Declares $0.5107 Quarterly Dividend; 1.3% Yield
-
CVS Health (CVS) Evercore Removes Two Names from TAP Outperform List
-
Cardinal Health (CAH) PT Raised to $157 at Citi
-
Cardinal Health (CAH) Tops Q3 EPS by 18c; raises outlook
-
Increasing unusual option volume: EWTX SLM HUYA IFF OLLI SMG GLBE EU VGK EC CAH
-
Cardinal Health (CAH) PT Raised to $150 at Mizuho
-
Cardinal Health (CAH) Appoints Robert Musslewhite and Sudhakar Ramakrishna to its Board
-
Increasing unusual put option volume: NE FEZ DB AMLP CAH BJ VSCO CMCSA CORT
-
Jefferies Upgrades Cardinal Health (CAH) to Buy
-
Cardinal Health (CAH) PT Raised to $142 at Mizuho
-
Cardinal Health (CAH) PT Raised to $130 at Citi
-
Cardinal Health (CAH) Tops Q2 EPS by 16c
-
Citi Reiterates Neutral Rating on Cardinal Health (CAH)
-
TD Cowen Upgrades Cardinal Health (CAH) to Buy
-
Evercore ISI Upgrades Cardinal Health (CAH) to Outperform
-
BofA Securities Upgrades Cardinal Health (CAH) to Buy
-
Senator Warren Asks FTC to Probe Cardinal Health-GI Alliance Deal - Bloomberg
-
T2 Biosystems (TTOO) Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
-
Mizuho Starts Cardinal Health (CAH) at Outperform
-
The election implications for healthcare technology and distribution stocks - BofA
-
Cardinal Health (CAH) Tops Q1 EPS by 26c; raises guidance
-
T2 Biosystems (TTOO) Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
-
TD Cowen Reiterates Hold Rating on Cardinal Health (CAH)
-
Cardinal Health (CAH) PT Raised to $140 at Baird
-
Cardinal Health (CAH) to acquire Integrated Oncology Network for $1.115B in cash
-
Cardinal Health (CAH) PT Raised to $125 at Argus
-
Cardinal Health (CAH) expands medical product distribution footprint in Northeast Ohio
-
Cardinal Health (CAH) PT Raised to $119 at Deutsche Bank

